Aker BioMarine AS (OSL: AKBM)
Norway
· Delayed Price · Currency is NOK 52.50
+1.80 (3.55%)
Nov 21, 2024, 4:25 PM CET
Aker BioMarine AS Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 334.8 | 335.3 | 277.2 | 262.1 | 288.59 | 246.17 | Upgrade
|
| Revenue | 334.8 | 335.3 | 277.2 | 262.1 | 288.59 | 246.17 | Upgrade
|
| Revenue Growth (YoY) | 47.81% | 20.96% | 5.76% | -9.18% | 17.23% | 59.66% | Upgrade
|
| Cost of Revenue | 225.9 | 222.4 | 162.4 | 174 | 176.03 | 150.89 | Upgrade
|
| Gross Profit | 108.9 | 112.9 | 114.8 | 88.1 | 112.56 | 95.28 | Upgrade
|
| Selling, General & Admin | 89 | 90.5 | 86.5 | 84.3 | 86.85 | 72.31 | Upgrade
|
| Other Operating Expenses | -5.1 | -4 | -4.4 | -2.7 | -0.09 | 2 | Upgrade
|
| Operating Expenses | 104.3 | 107.1 | 98.5 | 95 | 103.84 | 85.98 | Upgrade
|
| Operating Income | 4.6 | 5.8 | 16.3 | -6.9 | 8.72 | 9.3 | Upgrade
|
| Interest Expense | -20.4 | -33.4 | -20.3 | -13.7 | -18.74 | -22.79 | Upgrade
|
| Interest & Investment Income | 2.8 | 2.4 | 0.6 | - | 0.88 | 1.09 | Upgrade
|
| Earnings From Equity Investments | -3 | -3 | - | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -2.6 | -2.6 | 8.1 | 0.6 | -0.28 | -1.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.8 | -2.7 | -1.7 | -1.7 | 11.83 | -3.32 | Upgrade
|
| EBT Excluding Unusual Items | -21.4 | -33.5 | 3 | -21.7 | 2.41 | -16.8 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | - | -1.5 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0.4 | 1.31 | - | Upgrade
|
| Asset Writedown | -0.5 | -0.5 | - | -5.8 | -0.04 | -6.16 | Upgrade
|
| Other Unusual Items | - | - | 9.2 | 19.7 | -2.98 | - | Upgrade
|
| Pretax Income | -21.9 | -34 | 12.2 | -7.4 | 0.69 | -23.34 | Upgrade
|
| Income Tax Expense | -24.5 | -25 | 2.2 | 0.6 | 6.15 | 0.42 | Upgrade
|
| Net Income | 206.2 | -9 | 10 | -8 | -5.46 | -23.75 | Upgrade
|
| Net Income to Common | 206.2 | -9 | 10 | -8 | -5.46 | -23.75 | Upgrade
|
| Shares Outstanding (Basic) | 87 | 88 | 88 | 88 | 78 | 69 | Upgrade
|
| Shares Outstanding (Diluted) | 87 | 88 | 88 | 88 | 78 | 69 | Upgrade
|
| Shares Change (YoY) | -0.87% | 0.04% | 0.05% | 12.20% | 13.05% | - | Upgrade
|
| EPS (Basic) | 2.38 | -0.10 | 0.11 | -0.09 | -0.07 | -0.34 | Upgrade
|
| EPS (Diluted) | 2.38 | -0.10 | 0.11 | -0.09 | -0.07 | -0.34 | Upgrade
|
| Free Cash Flow | 14.6 | 1.5 | -25.4 | -76.1 | -72.7 | -114.6 | Upgrade
|
| Free Cash Flow Per Share | 0.17 | 0.02 | -0.29 | -0.87 | -0.93 | -1.66 | Upgrade
|
| Gross Margin | 32.53% | 33.67% | 41.41% | 33.61% | 39.00% | 38.70% | Upgrade
|
| Operating Margin | 1.37% | 1.73% | 5.88% | -2.63% | 3.02% | 3.78% | Upgrade
|
| Profit Margin | 61.59% | -2.68% | 3.61% | -3.05% | -1.89% | -9.65% | Upgrade
|
| Free Cash Flow Margin | 4.36% | 0.45% | -9.16% | -29.03% | -25.19% | -46.55% | Upgrade
|
| EBITDA | 46.8 | 49.9 | 61.1 | 38.5 | 49.75 | 43.33 | Upgrade
|
| EBITDA Margin | 13.98% | 14.88% | 22.04% | 14.69% | 17.24% | 17.60% | Upgrade
|
| D&A For EBITDA | 42.2 | 44.1 | 44.8 | 45.4 | 41.03 | 34.03 | Upgrade
|
| EBIT | 4.6 | 5.8 | 16.3 | -6.9 | 8.72 | 9.3 | Upgrade
|
| EBIT Margin | 1.37% | 1.73% | 5.88% | -2.63% | 3.02% | 3.78% | Upgrade
|
| Effective Tax Rate | - | - | 18.03% | - | 894.04% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.